Prognostic Value of RASSF1A Methylation Status in Non-Small Cell Lung Cancer (NSCLC) Patients: A Meta-Analysis of Prospective Studies.

Conclusion RASSF1A methylation in lung cancer tissue can serve as a prognostic factor of NSCLC. More studies are needed to uncover the underlying mechanisms.
PMID: 30764677 [PubMed - as supplied by publisher]

Source: Biomarkers - February 17, 2019 Category: Research Tags: Biomarkers Source Type: research